Effects of low-dose combined olanzapine and sertraline on negative and depressive symptoms in treatment-resistant outpatients with acute exacerbated schizophrenia

Background: Treatment-resistant schizophrenia (TRS) is a major clinical challenge. Current antipsychotic medications do not adequately address negative and depressive symptoms in patients with TRS, and novel treatments are thus needed. This study examines the efficacy of low-dose combined olanzapine...

Descripción completa

Detalles Bibliográficos
Autores principales: Lang, Xiaoe, Zang, Xiaocui, Yu, Feng, Xiu, Meihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160398/
https://www.ncbi.nlm.nih.gov/pubmed/37153770
http://dx.doi.org/10.3389/fphar.2023.1166507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160398/
https://www.ncbi.nlm.nih.gov/pubmed/37153770
http://dx.doi.org/10.3389/fphar.2023.1166507

Ejemplares similares